Citigroup upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY – Free Report) to a strong-buy rating in a research note released on Tuesday morning, Zacks.com reports.
A number of other equities analysts also recently issued reports on RBGLY. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an overweight rating to a neutral rating in a research report on Thursday, August 29th. UBS Group raised Reckitt Benckiser Group to a strong-buy rating in a research report on Wednesday, September 18th. One analyst has rated the stock with a sell rating, five have given a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of Hold.
Check Out Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Stock Up 0.5 %
Reckitt Benckiser Group Cuts Dividend
The company also recently announced a dividend, which was paid on Monday, September 23rd. Investors of record on Monday, August 5th were given a $0.1915 dividend. The ex-dividend date of this dividend was Monday, August 5th.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- The 3 Best Fintech Stocks to Buy Now
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.